AFP and hepatocellular carcinoma: To personalize posttransplant screening through risk stratification, several models have been developed to estimate the likelihood of HCC recurrence using various combinations of histologic features (e.g., vascular invasion, degree of differentiation, tumor viability), serum markers (e.g., alpha‐fetoprotein (AFP), AFP‐L3, des‐gamma‐carboxyprothrombin (DCP)) and donor factors (e.g., age) [6, 7, 8, 9, 10, 11, 12, 13].